Compass Therapeutics

IPO

Developing next generation antibodies into transformative cancer therapies

Public · Cambridge, United States · Founded 2014 · $332.0M raised

Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$332.0M
Last Round
$120.0M Venture RoundAug 2025
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Compass Therapeutics is a clinical-stage oncology biopharmaceutical company developing proprietary antibody-based therapeutics that target the tumor microenvironment. Their platforms enable rapid identification of therapeutic leads bridging the innate and adaptive immune system, with candidates designed to optimize critical components of anti-tumor immune responses. The company trades on Nasdaq under the ticker CMPX.

Summary

Compass Therapeutics is a Biotech company based in Cambridge, United States, founded in 2014. It has raised $332.0M in total across 3 rounds, most recently a $120.0M Venture Round in Aug 2025. Investors include OrbiMed, F-Prime Capital and Alumni Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Venture RoundVenture RoundAug 2025
$120.0M

Sign up to see all 4 events

Funding: Series A through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Compass Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/compass-therapeutics"><img src="https://indexed.vc/api/badge/company/compass-therapeutics" alt="Compass Therapeutics on Indexed.vc" width="260" height="76" /></a>